ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,369.07
-0.56%
Dow Jones
39,805.00
-0.17%
Gold vs US Dollar
2,388.08
-1.38%
Brent Oil
81.99
-0.55%
Bitcoin
70,564.01
0.61%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. BriaCell Therapeutics Corporation (BCTX) Share Price

BCTX BriaCell Therapeutics Corporation

1.52
0.03 (2.01%)
Last Updated: 16:28:56
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 BriaCell Therapeutics Corporation NASDAQ:BCTX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.03 2.01 1.52 1.51 1.53 1.56 1.473 1.56 13,171 15:28:56   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Aircraft  -20.3M -1.2703 -8.34 169.41M
 Type  Size  Price  Time  Units 
 6 100 1.52 15:28:56 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore BCTX News
17/05/202421:33GLOBEBriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
15/05/202413:00GLOBEBriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering
24/04/202413:00GLOBEBriaCell Announces Oral and Poster Presentations at ASCO 2024
10/04/202413:00GLOBEBriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer
09/04/202413:00GLOBEBriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR
07/03/202413:00GLOBEBriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies
06/03/202413:00GLOBEBriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference
Period
Draw mode
Data Downloads for BCTX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest BriaCell Therapeutics Corporation Articles